Skip to main content

Table 1 Demographic factors and baseline characteristics

From: Outcomes of treatment with CHOP and EPOCH in patients with HIV associated NHL in a low resource setting

Variable

All patients n = 120

CHOP, n = 108

DA-EPOCH, n = 12

Sex, n(%)

 Male

64 (53)

53 (49)

11(92)

 Female

56 (47)

55 (51)

1 (8)

Mean age, years (SD)

40 (10)

40(10.2)

42(8.1)

Mean BMI, kg/m2 (SD)

22 (4.7)

21 (4.6)

24(4.4)

NHL type, n(%)

 DLBCL

34 (28)

27 (25)

7(58)

 DLCL (IHC not done)

69 (58)

65 (60)

4(33)

 PBL

5 (4)

4 (4)

1(8)

 NHL Other

9 (8)

9 (8)

0

 Burkitt’s

3 (3)

3 (3)

0

ECOG score, n(%)

 0

9 (8)

8 (7)

1(8)

 1

29 (24)

22 (20)

7(58)

 2

12 (10)

12 (11)

0

 3

7 (6)

6 (6)

1(8)

 Not assessed

63 (53)

60 (56)

3(25)

B-Symptoms

 Yes

65 (54)

58 (54)

7(58)

 No

55 (46)

50 (46)

5(42)

Comorbidity

 Yes

17 (14)

14 (13)

3(25)

 No

103(86)

94 (87)

9(75)

Stage

 I

4 (3)

4 (4)

0

 II

21(18)

17(16)

4(33)

 III

54 (45)

48(44)

6(50)

 IV

21 (18)

19(18)

2(17)

 Not assessed

20 (17)

20(19)

0

  1. NB: DLBCL Diffuse large B-cell lymphoma, DLCL Diffuse large cell lymphoma, ECOG Easter Cooperative Oncology Group, IHC Immunohistochemistry, PBL Plasmablastic lymphoma; Comorbidity referred to the presence of any other diagnosis besides NHL